Phoenix Group, through its American subsidiary Phoenix Spark Inc., “brings” Predict S.p.A. – an innovative Italian SME in the med-tech sector and in vivo diagnostics – to the fifteenth edition of the Texas Life Science Forum in Houston, one of the leading events in the United States dedicated to innovation in Life Sciences and health tech, which began yesterday, November 10th, and will run through November 12th.
The mission is part of the first Life Sciences Innovation Trip promoted by Phoenix Group in collaboration with Fondazione Giacomo Brodolini, scheduled to coincide with the Texas Life Science Forum.
Co-organized by BioHouston and the Rice Alliance for Technology and Entrepreneurship, the 2026 edition of the event is being held at the Janice and Robert McNair Hall of the Jones Graduate School of Business, Rice University, and brings together emerging biotech, medtech, diagnostics, and digital health companies, investors, industry executives, and academic and clinical leaders from across the United States.
Starting yesterday, the TMCi hosted corporate pitches, panels on regulation and commercialization, funding opportunities and pathways, sessions dedicated to artificial intelligence in healthcare and neurodegenerative diseases, and networking moments. These were followed today by one-on-one meetings with investors, hosted right within the TMCi spaces—TMCi, Texas Medical Center Innovation, the innovation hub of the world’s largest medical complex, where one of the American offices of our subsidiary US Phoenix Spark is located.
After three Innovation Trips in the Bay Area in Silicon Valley, Phoenix Group is now, therefore, opening a vertical pathway in the life sciences sector, leveraging the positioning built in this field over the past two years, and strengthened by our presence at the TMCi.
The goal of this new project is to offer innovative Italian and European Life Sciences companies—and specifically Predict S.p.A.—direct access to the US ecosystem of industry stakeholders: research centers, clinical facilities, institutional and financial contacts, and industrial partners.
Listed on Euronext Growth Milan, Predict S.p.A. will be represented on the mission to Texas by Angelo Aurelio Gigante, Chairman and CEO of Predict, and by Simone Messina, Project Manager of the Mistral SBU.
“With this new initiative, Phoenix Group not only consolidates, through Phoenix Spark Inc., its role as a bridge between Italy, the EU, and the US, but does so within the Life Sciences world, one of the most innovative and challenging sectors, at the center of interest for operators and industrial partners. We are therefore proud to be able to bring to Houston, to the TMCi, and to one of the most important American scientific events, a company like Predict S.p.A., which works in health tech with the utmost attention to technological innovation, scientific collaborations, and investments in Research and Development,” said Antonio Casamassa, Executive Vice President of Phoenix Spark Inc, present in Houston alongside Paola Del Zotto Ferrari, Resident Director of Phoenix Spark.
“After our experiences in recent years at national and international life science and medical device trade shows, Houston represents for us a new opportunity for exchange within an ecosystem of excellence. We believe that engagement with the US ecosystem can open up new opportunities for collaboration and innovation,” declared Angelo Aurelio Gigante, Chairman and CEO of Predict.
